TCON   $1.43  -1.38% Market Closed

TRACON Pharmaceuticals Inc
Total Cash 6.27M
totalCashPerShare 1.84
EBITDA -9.29M
Total Debt 898.00K
quickRatio 0.634
currentRatio 0.658
Total Revenue 3.20M
debtToEquity
Revenue/Share 1.408
ROA -0.59373003
ROE
grossProfits
freeCashflow -11.97M
operatingCashflow 9.22M
earningsGrowth
revenueGrowth -0.994
grossMargins -2.78313
ebitdaMargins -2.90344
operatingMargins -52.94545
profitMargins 1.6234399
enterpriseValue -5.14M
forwardPE
floatShares 3.35M
sharesOutstanding 3.41M
sharesShort 166.13K
sharesShortPriorMonth 124.05K
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.04%
Short Ratio help_outline 0.95%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue -0.907
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon 5.20M
trailingEps 5.93%
forwardEps -0.19%
enterpriseToEbitda 0.55
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2024
institutionsCount 3
lastUpdated Oct. 22, 2024, 12:03 a.m.